• 166
  • 29
  • 收藏

Novavax Climbs as Its Covid Vaccine Recommended for EU Approval

Tiger Newspress2021-12-20

Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论29

  • 在於我們是
    ·2021-12-21
    Please like [Smile] 
    回复
    举报
  • Huatkor
    ·2021-12-21
    Up up and away!
    回复
    举报
  • SKHan
    ·2021-12-21
    Come on
    回复
    举报
  • SKHan
    ·2021-12-21
    Dips again
    回复
    举报
  • jojoc
    ·2021-12-21
    Ok
    回复
    举报
  • robot1234
    ·2021-12-21
    The omicron variant is raging across to the world as the winter holiday season approaches. U.S. cases are jumping into year-end with more than 156,000 reported on Friday, according to data from the Centers for Disease Control and Prevention.
    回复
    举报
    收起
    • robot1234
      Tks for sharing
      2021-12-22
      回复
      举报
    • robot1234
      Tks for sharing
      2021-12-22
      回复
      举报
    • yeppy
      Don't worry about the epidemic, the global economy will be liberalized in 2022. It is time to give up the vaccine stocks and buy airlines, cruises, and tourism stocks. Everyone has his own judgment. Good luck to us all.
      2021-12-21
      回复
      举报
  • dahae
    ·2021-12-21
    Qqqq
    回复
    举报
    收起
    • dahae
      Qqqq
      2021-12-21
      回复
      举报
  • Rajib
    ·2021-12-21
    Useful info
    回复
    举报
  • RO8
    ·2021-12-21
    Nice 
    回复
    举报
    收起
    • Huatkor
      Great!
      2021-12-21
      回复
      举报
  • WalterTam
    ·2021-12-20
    Ddd
    回复
    举报
  • corall
    ·2021-12-20
    [Miser] [Miser] 
    回复
    举报
  • DZL
    ·2021-12-20
    Novavax boosting its way up against Omicron
    回复
    举报
    收起
    • Andarian
      no news against omicron yet..
      2021-12-21
      回复
      举报
    • DZL
      certain growth short term for vaccine makers amidst uncertainty by omicron
      2021-12-20
      回复
      举报
  • woonws
    ·2021-12-20
    Finally for Novavax!
    回复
    举报
    收起
  • BKT
    ·2021-12-20
    Good. Pls like thanks.
    回复
    举报
  • TradeMore
    ·2021-12-20
    Ok
    回复
    举报
  • Yannnny
    ·2021-12-20
    Oo
    回复
    举报
    收起
    • Yannnny
      O
      2021-12-20
      回复
      举报
  • Siak
    ·2021-12-20
    Like
    回复
    举报
  • kencarrot
    ·2021-12-20
    Lol
    回复
    举报
    收起
    • huilly
      cool
      2021-12-21
      回复
      举报
    • kencarrot
      lol
      2021-12-20
      回复
      举报
  • dngggg
    ·2021-12-20
    nice
    回复
    举报
    收起
  • jshua
    ·2021-12-20
    Cool
    回复
    举报
    收起
    • iHuat
      Yah
      2021-12-20
      回复
      举报
    • dngggg
      kewl
      2021-12-20
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24